Philip Morris' IQOS Retains FDA Modified-Risk Authorization
Philip Morris wins renewed FDA backing for IQOS, keeping its modified-risk claims alive as the company accelerates its shift beyond cigarettes.
Open original sourceLoading market dashboard
Philip Morris wins renewed FDA backing for IQOS, keeping its modified-risk claims alive as the company accelerates its shift beyond cigarettes.
Open original source